Bay Colony Advisors’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$217K Sell
8,822
-13
-0.1% -$301 0.02% 454
2026
Q1
$211K Buy
+8,835
New +$216K 0.03% 458
2025
Q1
Sell
-10,093
Closed -$122K 460
2024
Q4
$122K Sell
10,093
-862
-8% -$11.3K 0.02% 437
2024
Q3
$161K Sell
10,955
-20
-0.2% -$279 0.02% 407
2024
Q2
$158K Buy
+10,975
New +$175K 0.03% 402
2022
Q4
Sell
-11,920
Closed -$148K 353
2022
Q3
$148K Buy
+11,920
New +$208K 0.04% 303

Other funds holding ELAN

Bay Colony Advisors's ELAN Position: Q2 2026 in Review

Bay Colony Advisors reduced its Elanco Animal Health (ELAN) stake by 0.15% in Q2 2026, selling an estimated $301 and leaving 8,822 shares worth $217K. The position accounts for 0.02% of the portfolio, ranked #454.

Bay Colony Advisors first reported a position in ELAN in Q3 2022 and has held it in 6 quarters since. 522 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Bay Colony Advisors held 8,822 shares of Elanco Animal Health worth $217K as of Q2 2026.
  • Bay Colony Advisors sold 13 Elanco Animal Health shares in Q2 2026, an estimated $301.
  • Elanco Animal Health made up 0.02% of Bay Colony Advisors's portfolio in Q2 2026, its #454 holding.
  • Bay Colony Advisors first reported a position in Elanco Animal Health in Q3 2022 and has held it in 6 quarters since.
  • 522 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Bay Colony Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.